1. Home
  2. BLFY vs BNR Comparison

BLFY vs BNR Comparison

Compare BLFY & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Foundry Bancorp

BLFY

Blue Foundry Bancorp

HOLD

Current Price

$13.07

Market Cap

185.3M

Sector

Finance

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$35.26

Market Cap

216.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLFY
BNR
Founded
1939
2014
Country
United States
China
Employees
N/A
N/A
Industry
Commercial Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
216.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BLFY
BNR
Price
$13.07
$35.26
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
483.7K
34.1K
Earning Date
01-21-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,731,000.00
$75,749,382.00
Revenue This Year
$19.85
$136.32
Revenue Next Year
$20.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.52
5.56
52 Week Low
$7.61
$2.18
52 Week High
$13.55
$41.72

Technical Indicators

Market Signals
Indicator
BLFY
BNR
Relative Strength Index (RSI) 60.49 65.54
Support Level $12.77 $35.00
Resistance Level $13.55 $41.72
Average True Range (ATR) 0.36 3.30
MACD -0.02 0.70
Stochastic Oscillator 69.65 72.87

Price Performance

Historical Comparison
BLFY
BNR

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: